Viewing Study NCT00535951


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-01-04 @ 7:47 PM
Study NCT ID: NCT00535951
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2007-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLBH589B2109
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators